Stephen K. Carter

6.9k total citations · 3 hit papers
88 papers, 5.4k citations indexed

About

Stephen K. Carter is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stephen K. Carter has authored 88 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 23 papers in Molecular Biology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stephen K. Carter's work include Cancer Treatment and Pharmacology (27 papers), Chemotherapy-induced cardiotoxicity and mitigation (14 papers) and Lung Cancer Treatments and Mutations (12 papers). Stephen K. Carter is often cited by papers focused on Cancer Treatment and Pharmacology (27 papers), Chemotherapy-induced cardiotoxicity and mitigation (14 papers) and Lung Cancer Treatments and Mutations (12 papers). Stephen K. Carter collaborates with scholars based in United States, Malaysia and Germany. Stephen K. Carter's co-authors include Ronald H. Blum, Stanley T. Crooke, Robert L. Comis, Michael Friedman, Robert B. Livingston, Archie W. Prestayko, Todd H. Wasserman, Milan Slavik, Sewa S. Legha and Renzo Canetta and has published in prestigious journals such as Annals of Internal Medicine, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Stephen K. Carter

85 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A clinical review of bleomycin—a new antineoplastic agent

1973 699 citations Ronald H. Blum, Stephen K. Carter et al. Cancer profile →
Cisplatin : current status and new developments

1980 608 citations Archie W. Prestayko, Stanley T. Crooke et al. Academic Press eBooks profile →
Adriamycin—A Review

1975 406 citations Stephen K. Carter profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen K. Carter United States	37	2.4k	1.5k	1.2k	884	698	88	5.4k
Marcel Rozencweig Belgium	30	1.9k 0.8×	998 0.7×	695 0.6×	393 0.4×	598 0.9×	151	4.0k
E Frei United States	42	2.2k 0.9×	1.8k 1.2×	1.2k 1.0×	492 0.6×	885 1.3×	104	6.1k
W.W. ten Bokkel Huinink Netherlands	46	3.8k 1.6×	2.1k 1.5×	750 0.6×	1.4k 1.6×	540 0.8×	160	6.9k
A. Hilary Calvert United Kingdom	37	3.0k 1.2×	2.3k 1.5×	1.1k 0.9×	619 0.7×	1.1k 1.6×	75	5.9k
Sewa S. Legha United States	46	4.0k 1.6×	1.7k 1.2×	1.1k 0.9×	352 0.4×	448 0.6×	138	6.4k
M. E. Scheulen Germany	36	2.6k 1.1×	2.3k 1.5×	1.2k 1.0×	422 0.5×	612 0.9×	178	5.5k
Jeffrey A. Gottlieb United States	32	2.6k 1.1×	946 0.6×	1.2k 1.0×	499 0.6×	1.0k 1.5×	73	5.2k
Youcef M. Rustum United States	51	3.7k 1.5×	3.5k 2.4×	1.3k 1.1×	865 1.0×	726 1.0×	246	8.2k
Scot C. Remick United States	38	2.8k 1.1×	1.5k 1.0×	1.0k 0.9×	656 0.7×	818 1.2×	156	6.1k
Scott Wadler United States	43	4.5k 1.9×	2.0k 1.4×	1.9k 1.6×	1.9k 2.1×	975 1.4×	192	8.1k

Countries citing papers authored by Stephen K. Carter

Since Specialization

Citations

This map shows the geographic impact of Stephen K. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen K. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen K. Carter more than expected).

Fields of papers citing papers by Stephen K. Carter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen K. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen K. Carter. The network helps show where Stephen K. Carter may publish in the future.

Co-authorship network of co-authors of Stephen K. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen K. Carter. A scholar is included among the top collaborators of Stephen K. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen K. Carter. Stephen K. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Bergan, Raymond C., et al.. (2001). Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer. Urology. 57(4). 77–80. 20 indexed citations

2.

Carter, Stephen K.. (1995). Cancer chemotherapy 1973?present: A personal perspective. Journal of Cancer Research and Clinical Oncology. 121(9-10). 501–504. 2 indexed citations

3.

Carter, Stephen K.. (1987). Improving the therapeutic index of systemic therapy with special emphasis on cisplatin and carboplatin. Cancer Treatment Reviews. 14(3-4). 179–185. 6 indexed citations

4.

Carter, Stephen K. & John E. Ultmann. (1984). Peplomycin. Cancer Treatment Reviews. 11(4). 303–305. 5 indexed citations

5.

Carter, Stephen K.. (1982). The potential lack of comparability between interim and final results of cancer clinical trials. Cancer Chemotherapy and Pharmacology. 8(1). 1–2. 4 indexed citations

6.

Muggia, Franco M., Stephen K. Carter, & John S. Macdonald. (1981). The Cancer Therapy Evaluation Program of the National Cancer Institute.. PubMed. 8(4). 394–402. 8 indexed citations

7.

Prestayko, Archie W., et al.. (1980). Cisplatin : current status and new developments. Academic Press eBooks. 608 indexed citations breakdown →

8.

Phillips, Theodore L., Ivan Silverberg, Karen K. Fu, et al.. (1980). Interim report on a phase III study of bleomycin and methotrexate with radiotherapy in the treatment of inoperable head and neck cancer. International Journal of Radiation Oncology*Biology*Physics. 6(10). 1447–1447. 2 indexed citations

9.

Carter, Stephen K.. (1980). The old versus the new combinatons: Drugs and irradiation for head and neck cancer. International Journal of Radiation Oncology*Biology*Physics. 6(5). 641–644. 3 indexed citations

10.

Carter, Stephen K., et al.. (1978). Bleomycin : current status and new developments. Academic Press eBooks. 86 indexed citations

11.

Carter, Stephen K., et al.. (1976). Fundamental and clinical studies of bleomycin. 21 indexed citations

12.

Carter, Stephen K.. (1976). Immunotherapy of cancer in man.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 64(4). 418–23. 4 indexed citations

13.

Legha, Sewa S., Milan Slavik, & Stephen K. Carter. (1976). Nafoxidine–-an antiestrogen for the treatment of breast cancer. Cancer. 38(4). 1535–1541. 32 indexed citations

14.

Legha, Sewa S., Milan Slavik, & Stephen K. Carter. (1976). Hexamethylmelamine.An evaluation of its role in the therapy of cancer. Cancer. 38(1). 27–35. 70 indexed citations

15.

Carter, Stephen K., et al.. (1975). Current therapies in osteosarcoma. Cancer Treatment Reviews. 2(1). 77–83. 8 indexed citations

16.

Goldsmith, Michael & Stephen K. Carter. (1974). Glioblastoma multiforme—A review of therapy. Cancer Treatment Reviews. 1(2). 153–165. 34 indexed citations

17.

Blum, Ronald H., et al.. (1973). A clinical review of bleomycin—a new antineoplastic agent. Cancer. 31(4). 903–914. 699 indexed citations breakdown →

18.

Carter, Stephen K.. (1973). Single-Agent Therapy for Hodgkin's Disease. Archives of Internal Medicine. 131(3). 377–377. 28 indexed citations

19.

Burchenal, Joseph H. & Stephen K. Carter. (1972). New cancer chemotherapeutic agents. Cancer. 30(6). 1639–1646. 19 indexed citations

20.

Livingston, Robert B. & Stephen K. Carter. (1970). Single Agents in Cancer Chemotherapy. 268 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact